Study Links Type 2 Diabetes Treatment to Alzheimer’s Disease and Dementia Risk

Overview of Type 2 Diabetes and Cognitive Function

A recent study published in *Diabetes Care* explored the connection between type 2 diabetes treatment and the risk of developing Alzheimer’s disease and dementia. Type 2 diabetes, a condition where the body struggles to regulate blood sugar levels, has been associated with deteriorated cognitive functions. Research indicates that individuals with type 2 diabetes exhibit poorer verbal memory, slower information processing speed, diminished attention, and compromised executive function compared to their healthy counterparts.

Inconclusive Findings on Diabetes and Alzheimer’s Disease

Despite the observed cognitive impairments, studies investigating the relationship between type 2 diabetes and Alzheimer’s disease have yielded mixed results. For example, autopsy studies have shown no significant association between type 2 diabetes and Alzheimer’s disease biomarkers. Conversely, population-based studies indicate that undiagnosed diabetes may heighten the risk of dementia and Alzheimer’s disease when compared to well-managed diabetes and healthy individuals. Furthermore, animal studies suggest that various diabetes medications may offer neuroprotective and cognitive advantages.

Significance of Identifying Type 2 Diabetes as a Risk Factor

Recognizing type 2 diabetes as a potential risk factor for Alzheimer’s disease and dementia could enhance clinicians’ ability to educate patients and implement measures aimed at improving their overall health and quality of life.

Study Design and Participant Groups

The recent observational study categorized participants into four groups:
– Normal sugar level group
– Pre-diabetes group (PD)
– Untreated diabetes group (UD)
– Treated diabetes group (TD)

The researchers assessed the cerebrospinal fluid (CSF) of each participant for Alzheimer’s disease markers, specifically phosphorylated Tau (p-Tau), total Tau (t-Tau), and Aβ1-42. They also monitored the participants’ progression to dementia over a 120-month period.

Key Findings from the Research

During the follow-up, a total of 331 participants progressed to dementia. The untreated diabetes group exhibited a more accelerated progression towards dementia compared to those with normal sugar levels. Additionally, the UD group demonstrated elevated levels of p-Tau and t-Tau relative to the other three groups. However, there was no significant difference in Aβ1-42 levels among the four groups.

Conclusion of the Study

The study concluded that adults with unmanaged type 2 diabetes have higher levels of Alzheimer’s disease markers and experience a faster progression to dementia compared to healthy individuals and those with well-managed type 2 diabetes. The authors advocate for the effective management and treatment of type 2 diabetes as a potential strategy to reduce the risk of dementia and Alzheimer’s disease.

Written by Haisam Shah, BSc
Reference: McIntosh, E. C., & Nation, D. A. (2019). Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer Disease. *Diabetes Care*.